Loading...
Loading...
In a research report published earlier today, Morgan Stanley has lowered Molycorp, Inc.'s
MCP PT to $81 in order to factor in equity issuance.
Morgan Stanley commented in the report, “MCP has fallen 3% on average post-earnings since the IPO in mid-2010. Disappointed by the 3Q revenue miss and lower 4Q volume guidance, investors are concerned about any delay to the 2012 mill start-up and uncertainty on near-term sales mix and cost inflation. We think most of the cash from the recent primary issue will go to downstream integration, but MCP has not announced a plan. Investors should reward mill execution and clarity on use of cash.”
Morgan Stanley reiterates its Overweight rating on Molycorp, which closed Friday at $28.06.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in